These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
434 related items for PubMed ID: 1840244
1. [Respective importance of vertical and horizontal transmission of hepatitis B in the Australian archipelago (French Polynesia). Preliminary results of the vaccination of newborns]. Boutin JP, Spiegel A, Flye Sainte-Marie F, Cartel JL, Girard M, Saliou P, Roux J. Bull Soc Pathol Exot; 1991; 84(5 Pt 5):906-11. PubMed ID: 1840244 [Abstract] [Full Text] [Related]
2. [Control of hepatitis B in French Polynesia with a program of systematic vaccination of newborns with the Genhevac B vaccine]. Moulia-Pelat JP, Spiegel A, Excler JL, Martin P, Roux JF, Boutin JP, Blondeau C, Saliou P. Sante; 1996; 6(1):11-5. PubMed ID: 8612008 [Abstract] [Full Text] [Related]
3. [Materno-fetal transmission of hepatitis B virus in Ivory Coast. Plea for mass vaccination]. Lohouès-Kouacou MJ, Touré M, Hillah J, Camara BM, N'Dri N, Kouamé KJ, Attia Y. Sante; 1998; 8(6):401-4. PubMed ID: 10064911 [Abstract] [Full Text] [Related]
5. Vaccination against hepatitis B virus infection in neonates. Pongpipat D, Suvatte V, Assateerawatts A. Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403 [Abstract] [Full Text] [Related]
6. Perinatal and intrafamily transmission of hepatitis B virus in three generations of a low-prevalence population. Ordög K, Szendrôi A, Szarka K, Kugler Z, Csire M, Kapusinszky B, Xie J, Csizmadia K, Brojnás J, Rusvai E, Tempfli A, Berencsi G. J Med Virol; 2003 Jun; 70(2):194-204. PubMed ID: 12696105 [Abstract] [Full Text] [Related]
8. Impact of the hepatitis B mass vaccination program in the southern part of Thailand. Chub-uppakarn S, Panichart P, Theamboonlers A, Poovorawan Y. Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):464-8. PubMed ID: 10437940 [Abstract] [Full Text] [Related]
9. [Immunogenicity of the vaccine against hepatitis B virus in schoolchildren of Madrid]. Gil Miguel A, Lasheras Lozano ML, Vizcaino MJ, del Rey Calero J, Martín Hernández D. Rev Sanid Hig Publica (Madr); 1992 Sep; 66(2):149-56. PubMed ID: 1366248 [Abstract] [Full Text] [Related]
10. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness. de la Hoz F, Perez L, de Neira M, Hall AJ. Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535 [Abstract] [Full Text] [Related]
11. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan. Lu JJ, Cheng CC, Chou SM, Hor CB, Yang YC, Wang HL. Vaccine; 2009 Nov 05; 27(47):6613-8. PubMed ID: 19698812 [Abstract] [Full Text] [Related]
12. Continuing risk for hepatitis B virus transmission among Southeast Asian infants in Louisiana. Mahoney FJ, Lawrence M, Scott C, Le Q, Lambert S, Farley TA. Pediatrics; 1995 Dec 05; 96(6):1113-6. PubMed ID: 7491231 [Abstract] [Full Text] [Related]
13. HBV and HCV infection in Japanese dental care workers. Nagao Y, Matsuoka H, Kawaguchi T, Ide T, Sata M. Int J Mol Med; 2008 Jun 05; 21(6):791-9. PubMed ID: 18506374 [Abstract] [Full Text] [Related]
14. [Long-term efficacy and persistence of Chinese infants after receiving only active plasma-derived hepatitis B vaccine]. Xia G, Jia Z, Yan T, Li R, Liu H, Xu Z, Cao H, Liu C. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun 05; 16(2):146-9. PubMed ID: 12196826 [Abstract] [Full Text] [Related]
15. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection. Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH. J Pediatr Gastroenterol Nutr; 2009 Feb 05; 48(2):203-8. PubMed ID: 19179883 [Abstract] [Full Text] [Related]
16. [Observation on effects of hepatitis B vaccine immunization for 12 years in children in Beijing]. Gong XH, Wang FZ, Li H, Liu LR, Li YH, Wang BL, Li LQ, Zhang Z, Han QY, Tang YW. Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Jul 05; 39(4):265-8. PubMed ID: 16194384 [Abstract] [Full Text] [Related]
17. [Prevalence of hepatitis A, B, C virus markers in Réunion (south hospital and Saint Pierre prison)]. Michault A, Faulques B, Sevadjan B, Troalen D, Marais A, Barau G. Bull Soc Pathol Exot; 2000 Feb 05; 93(1):34-40. PubMed ID: 10774493 [Abstract] [Full Text] [Related]
18. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal). Coursaget P, Deciron F, Tortey E, Barin F, Chiron JP, Yvonnet B, Diouf C, Denis F, Diop-Mar I, Correa P. IARC Sci Publ; 1984 Feb 05; (63):319-35. PubMed ID: 6242150 [Abstract] [Full Text] [Related]
19. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study. Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP. Pediatr Infect Dis J; 2008 Oct 05; 27(10):881-5. PubMed ID: 18756185 [Abstract] [Full Text] [Related]
20. Seroepidemiological study for HBV markers and anti-delta in Kenya. Okoth FA, Kobayashi M, Kaptich DC, Kaiguri PM, Tukei PM, Takayanagi T, Yamanaka T. East Afr Med J; 1991 Jul 05; 68(7):515-25. PubMed ID: 1756703 [Abstract] [Full Text] [Related] Page: [Next] [New Search]